Chapter 34. Technology Providers and Integrators-a Virtual Architecture for Drug R & D?

Annual Reports in Medicinal Chemistry

Volumn 33, Issue C, 1998, Pages 365-374

  Cavalla, David ^a  

^a ST JOHN S COLLEGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0012169829     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-7743(08)61099-4     Document Type: Chapter

References (23)

1. Drews J., and Ryser S. Drug Discovery Today 2 (1997) 365
2. Sykes, R., Centre for Medicines Research (Carshalton, Surrey, UK) Annual Lecture, 1997
3. Baxter A.D. Drug Discovery Today 2 (1997) 307
4. Wintner E.A., and Rebek J. In: Wilson S., and Czarnik A. (Eds). "Combinatorial Chemistry" (1997), J. Wiley, Chichester 95
5. Storer R. Drug Discovery Today 1 (1996) 249
6. Kilpatrick M. Scrip Magazine (1995)
7. Wallace R.W. Drug Discovery Today 2 (1997) 355
8. Banerjee P.K., and Rosofsky M. "Re-inventing Drug Discovery" (1997), Andersen Consulting, Chicago
9. Lloyd A.W. Drug Discovery Today 2 (1997) 397
10. Cashman J.R. Drug Discovery Today 1 (1996) 209
11. Khan, K.A., 3rd IBC Meeting on Lead Identification to Candidate Selection, London, 22-23 Sep, 1997
12. Lehman Brothers London, Pharma Pipelines, 1996
13. Taaffe, P., "Outsourcing in the Pharmaceutical Industry", Financial Times Management Report 1996
14. Cavalla D., Flack J., and Jennings R. "Modern Strategy for Preclinical Pharmaceutical R & D" (1997), J. Wiley, Chichester, UK
15. Aldridge, A., 3rd IBC Meeting on Pharmaceutical Pre-clinical Development, London, 13-14 Oct, 1997
16. Mark R., and Clark W.W. Scientific American 251 (1984) 296
17. Thomas, F., Scrip Magazine, July/August, 14 (1996)
18. Anon, Scrip, 2228, 10 (1997)
19. Anon, Scrip, 2184, 19 (1996)
20. Cavalla D., and Gale D.D. Drug News and Perspectives 10 (1997) 470
21. Anon, Scrip, 2140, 17 (1996)
22. Berggren, R., Blanc, A. and Krinke, L., In Vivo, May, 11 (1996)
23. Mellor, N. and Allary, C., Scrip Magazine, September, 53 (1996)